Preview

Nephrology (Saint-Petersburg)

Advanced search

STRUCTURAL AND FUNCTIONAL STATE OF THE HEART AND CORONARY BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES WITH NEPHROPATHY

https://doi.org/10.24884/1561-6274-2011-15-1-48-53

Abstract

THE AIM. To assess changes in coronary blood flow and the structural and functional features of heart disease in diabetic patients with different stages of diabetic nephropathy (DN). PATIENTS AND METHODS. It was investigated 142 patients with type 2 diabetes. The diagnosis of diabetic nephropathy was established with the help of quantitative evaluation method of albumin in the first morning urine (three times).Survey methods included transthoracic echocardiography, single photon emission computed tomography (SPECT) at rest and with pharmacological stress ATP, bicycle ergometry, ECG monitoring. RESULTS. It was found that the thickness of the left ventricle in patients with DN, higher than that in patients without DN. The progression of DN was associated with an increase in left ventricular mass (LVMM) and LVMM index, end systolic and end diastolic volume, decreased left ventricular ejection fraction. It was shown a reduction in absolute parameters of transmitral flow in combination with an increase in the index E/A in patients with microalbuminuria and pseudonormalization specified rate in patients with proteinuria. In patients with proteinuria during cycle ergometry were more prevalent ischemic myocardial changes, but according to pharmacological stress SPECT revealed no deterioration in coronary perfusion compared with the rest in either group. CONCLUSION. Microalbuminuric stage of diabetic nephropathy is characterized by myocardial hypertrophy and diastolic left ventricular dysfunction, reduced systolic function at the intellectual and emotional stress. Proteinuric stage of diabetic nephropathy is associated with myocardial hypertrophy and diastolic left ventricular dysfunction, reduced global myocardial
contractility at rest, a significant deterioration in coronary blood flow. Leading role in reducing coronary blood flow with the progression of diabetic nephropathy is microvascular ischemia.

About the Authors

S. I. POPOV
Военно-медицинская академия им. С.М. Кирова
Russian Federation


O. A. NAGIBOVICH
Военно-медицинская академия им. С.М. Кирова
Russian Federation


S. B. SHUSTOV
Военно-медицинская академия им. С.М. Кирова
Russian Federation


References

1. Portolеs Pеrez J, Cuevas Bou X. Cardiorenal syndrome.Nefrologia 2008; 28 [Suppl 3]: 29–32

2. Смирнов АВ, Добронравов ВА, Каюков ИГ. Кардиоренальный континуум: патогенетические основы превентивной нефрологии. Нефрология 2005; 9 (3): 7–15

3. Дедов ИИ, Шестакова МВ. Диабетическая нефропатия. Универсум Паблишинг, М., 2000; 240

4. Добронравов ВА. Современные подходы к диагностике и лечению диабетической нефропатии. Нефрология 2003; (2): 93-100

5. Mogensen CE, Damsgaard EM., Froland A et al. Microalbuminuria in noninsulin-dependent diabetes: [Review]. Clin Nephrol 1992; 38 [Suppl 1]: 528–539

6. Шестакова МВ, Сунцов ЮИ, Дедов ИИ. Диабетическая нефропатия: состояние проблемы в мире и в России.Сахарный диабет 2001; 12(3): 2–4

7. Нагибович ОА. Состояние сердечно-сосудистой системы при диабетической нефропатии. Автореф. дис. …д-р мед наук, СПб., 2004; 36

8. Cimino A, Rocca L, Girelli A, Valentini V. The relationshipbetween diabetic nephropathy and ischemic cardiopathy: study of an out-patient type 2 diabetic population. Diabetologia 1998; (41) [Suppl 1]: A292

9. Parving HH, Nielsen FS, Bang LE et al. Macro- microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 1996; 39 (12): 1590–1597

10. Nielsen FS, Voldsgaard AI, Gall MA et al. Apolipoprotein (a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 1993; 36 (5): 438–444

11. Wang SL, Head J, Stevens L, Fuller JH. Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes. Diabetes Care 1996; 19 (4): 305–312

12. Chandy A et al. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transpl 2008; 6 (19): 924–928

13. Deveci OS et al. The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis. Angiology 2010; 2 (61): 184–191

14. Schmiedel O, Schroeter ML, Harvey JN. Microalbuminuria in Type 2 diabetes indicates impaired microvascular vasomotion and perfusion. Am J Physiol Heart Circ Physiol 2007; 6 (293): H3424–3431

15. Varghese K, Cherian G, Abraham MT et al. Coronary artery disease among diabetic and non-diabetic patients with end stage renal disease. Ren Fail 2001; 23 (5): 669–677

16. Cosson E, Paycha F, Tellier P et al. Lowerlimb vascularization in diabetic patients. Assessment by thallium- 201 scanning coupled with exercise myocardial scintigraphy. Diabetes Care 2001; 24 (5): 870–874

17. Dankowski R, Wierzchowiecki M, Naskret D et al. Association between retinopathy, microalbuminuria and coronary perfusion in young patients with type 1 diabetes mellitus. Kardiol Pol 2008; 3 (66): 262–268

18. Балаболкин МИ. Диабетология Медицина, М., 2000;672

19. Гупалова ТВ, Орлова СН, Палагнюк ВГ и др. Определение микроальбуминурии с применением рекомбинантного альбуминового рецептора. Клин лаб диагн 1997; (2):14–16

20. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy. Diabetes 1983; (32) [Suppl 2]: 64–78

21. Шиллер Н, Осипов МА. Клиническая эхокардиография. Мир, М., 1993; 347

22. Новиков ВИ. Методика эхокардиографии. CПбМАПО, СПб., 1994; 9–47

23. Devereux RB. Metods of recognition and assessment of left ventricular hypertrophy. Mediographia 1995; 17 (1): 12–16

24. Алехин МН, Седов ВП. Допплерэхокардиография.Б.и., М., 1996; 11–80

25. Шустов СБ, Халимов ЮШ, Труфанов ГЕ. Функциональная и топическая диагностика в эндокринологии, 2-е изд., перераб. и доп. ЭЛБИ СПб, СПб., 2010; 294

26. Tani N et al. Asymptomatic ischemic heart disease and diabetic nephropathy: relationship between prevalence of asymptomatic ischemic heart disease and urinary albumin excretion rate. J Diabet Complications 1991; 5 (2-3): 169–170


Review

For citations:


POPOV S.I., NAGIBOVICH O.A., SHUSTOV S.B. STRUCTURAL AND FUNCTIONAL STATE OF THE HEART AND CORONARY BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES WITH NEPHROPATHY. Nephrology (Saint-Petersburg). 2011;15(1):48-53. (In Russ.) https://doi.org/10.24884/1561-6274-2011-15-1-48-53

Views: 339


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)